The market often fails to price in the full effect of deregulation immediately. Policy changes can take a year or more to translate into improved corporate earnings. This creates a potential opportunity as the market is likely to re-rate these companies only after the financial benefits become visible.

The market struggles to price exponential growth, creating opportunities to buy dominant tech companies at low forward earnings multiples (e.g., Nvidia at 4x). An understanding of S-curve adoption reveals this underappreciated earnings power before the market catches on.

The rapid market share gains of Chinese electric vehicles in Europe pose a significant risk to the continent's automotive supply chain. Since Chinese OEMs often use cheaper, domestic components, they can shrink the total addressable market for premium Western suppliers like Seeing Machines, even as total vehicle sales grow.

Once a TransDigm part is certified for a specific aircraft model, it cannot be substituted for the plane's entire 30-50 year lifespan. This regulatory lock-in creates hundreds of mini-monopolies, giving TransDigm immense and durable pricing power on replacement parts.

Firefighter breathing apparatus (SCBAs) must be replaced every 10-15 years by law. This creates predictable, recurring revenue opportunities for MSA, which the market often discounts or treats as a mere possibility rather than a near certainty, presenting an investment opportunity.

Samsara capitalized on the ELD mandate, a government regulation that forced the entire trucking industry to buy electronic logging devices. This tailwind created instant, industry-wide budget for their product, allowing them to rapidly gain market share against incumbents like AT&T and Verizon.

The investment case for a company benefiting from new regulations can be framed powerfully. Comparing Seeing Machines to a seatbelt manufacturer just before seatbelts became mandatory effectively communicates the scale of the imminent, regulation-driven market expansion from a niche product to a universal standard.

Over a decade, OTC Markets' free cash flow grew at 14% annually, while revenue grew at 11%. This three-percentage-point gap indicates significant operating leverage, as the business can grow profits and cash flow much faster than its top line without proportional cost increases.

A change in regulatory standards is a powerful market catalyst. It creates an urgent, non-discretionary need for a new solution, shifting the customer conversation from "We're fine" to "We need help now," which dramatically accelerates adoption and reduces sales friction.